Table 1.
The analysis of drug interaction in cell growth assay as in Fig. 2F using multiple statistical methods described in Supplementary Methods.
Models | Drug interaction Parameter | Estimated | 95% Cl | Conclusion | ||
---|---|---|---|---|---|---|
Syn. | Add. | Ant. | ||||
II < 1 | II = 1 | II > 1 | ||||
Chou and Talalay | Eribulin=1, MLN =50 | 0.688 | (0.573, 0.825) | Synergy | ||
Eribulin=3, MLN =100 | 0.468 | (0.334, 0.654) | Synergy | |||
Eribulin=5, MLN =100 | 0.669 | (0.519, 0.866) | Synergy | |||
Eribulin=3, MLN =150 | 0.427 | (0.269, 0.677) | Synergy | |||
Eribulin=5, MLN =150 | 0.505 | (0.345, 0.738) | Synergy | |||
Greco | α>0 | α=0 | α<0 | 0.949 | (0.187, 1.711) | Synergy |
Machado | 0<h<1 | h=0 | h>1 | 0.613 | (0.474, 0.753) | Synergy |